Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis

Table 1 Sample information of AYAs cancer patients

No. AYA^a	Age	Sex	Tumor type	Tissue type	Previous treatment^b	Platform
No. AYA^a	Age	Sex	Tumor type	Tissue type	Previous treatment^b	WES	WTS	OncoScan
#01	30	M	Prostate cancer	Fresh-frozen	Docetaxel + Pd	v	v	v
#02	30	M	Olfactory neuroblastoma	Fresh-frozen	ICE	v	v	-
					Op
					PORT
#04	33	M	Head and neck squamous cell carcinoma	Fresh-frozen	Op	v	-	v
					CCRT
					DP
					Cetuximab
					FP
					Op
#06	32	M	Urachalcarcinoma	FFPE	Op	v	-	v
#07	21	M	Germ cell tumor	Fresh-frozen	Op	v	-	v
					BEP
					IE
#09	34	M	Lung cancer	Pleurisy	-	-	v	-
#10	33	M	Liposarcoma	Fresh-frozen	Op	v	v	v

^a#03: exclusion, because of no tumor sample provided; #05, 08: exclusion, because of insufficient sample to sequencing
^b Pd prednisolone, ICE ifosfamide + carboplatin + etoposide, Op operation, PORT postoperative radiotherapy, CCRT concurrent chemoradiotherapy, DP docetaxel + cisplatin, FP 5-fluorouracil + cisplatin, BEP bleomycin + etoposide + cisplatin, IE ifosfamide + etoposide

ISSN: 1471-2407